Korea Investment Corp Nektar Therapeutics Transaction History

Korea Investment Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$31.0 - $36.3 $4.83 Million - $5.65 Million	-155,700 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $4.85 Million - $7.12 Million	153,708 Added 7716.27%	155,700 $5.23 Million
Q4 2018 Feb 13, 2019	SELL	$30.43 - $56.65 $3.22 Million - $5.99 Million	-105,788 Reduced 98.15%	1,992 $65,000
Q3 2018 Nov 13, 2018	BUY	$46.46 - $68.49 $3.23 Million - $4.77 Million	69,592 Added 182.24%	107,780 $6.57 Million
Q2 2018 Aug 13, 2018	BUY	$46.25 - $104.45 $1.77 Million - $3.99 Million	38,188 New	38,188 $0

146

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $197M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Korea Investment Corp with notifications on news.